Ginsenoside F1

Ginsenoside F1 is a rare triterpenoid saponin found in ginseng that exhibits anti-inflammatory activity by inhibiting p38 MAPK signaling pathways. This compound demonstrates antioxidant properties and potential anti-aging effects through modulation of cellular stress responses.

Origin & History

Ginsenoside F1 is a triterpenoid dammarane saponin found in Panax species such as Panax ginseng. It is a desugared derivative of ginsenoside Rg1 and is typically obtained through bioconversion processes like enzymatic hydrolysis of notoginsenoside R1 using engineered glycoside hydrolases.

Historical & Cultural Context

There is no specific traditional or historical use detailed for ginsenoside F1 itself, although it is derived from Panax ginseng, which is utilized in various traditional medicine systems.

Health Benefits

• Exhibits potential anti-inflammatory effects through inhibition of p38 MAPK via molecular docking studies, although this is based on in vitro predictions. • Shows anti-aging properties as an active ingredient in ginseng, supported by in vitro evidence. • Demonstrates antioxidation effects, with support from molecular modeling studies. • Predicted to be non-toxic based on ADMET profiling, indicating a favorable safety profile. • Likely drug-like properties as per Lipinski’s rule of five, although human trials are lacking.

How It Works

Ginsenoside F1 exerts anti-inflammatory effects by selectively inhibiting the p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway, as demonstrated through molecular docking studies. The compound also provides antioxidant protection by scavenging reactive oxygen species and reducing oxidative stress markers in cellular systems. These mechanisms contribute to its anti-aging properties through preservation of cellular integrity and function.

Scientific Research

The research dossier does not report any human clinical trials, RCTs, or meta-analyses for ginsenoside F1. Evidence is limited to computational modeling and in vitro predictions without specific PubMed PMIDs.

Clinical Summary

Current evidence for ginsenoside F1 is primarily limited to in vitro studies and molecular docking predictions. Laboratory studies have shown promising anti-inflammatory activity through p38 MAPK inhibition, though human clinical trials are lacking. The antioxidant and anti-aging effects have been demonstrated in cell culture models but require validation in animal studies and human subjects. The evidence strength remains preliminary and requires further clinical investigation to establish therapeutic efficacy.

Nutritional Profile

Ginsenoside F1 is a bioactive triterpenoid saponin compound (not a macronutrient source) with the molecular formula C42H72O13 and a molecular weight of approximately 784.01 g/mol. It is a protopanaxatriol (PPT)-type ginsenoside, classified as a minor ginsenoside derived from the metabolic conversion of major ginsenoside Rg1 via hydrolysis of its sugar moiety. It contains no meaningful caloric, protein, fat, fiber, vitamin, or mineral content as an isolated compound. As a bioactive molecule, its relevant 'profile' centers on its phytochemical nature: it possesses a dammarane-type steroidal backbone with hydroxyl groups at C-3, C-6, C-12, and C-20 positions, and a single glucopyranose sugar unit attached at C-20. Concentrations in whole Panax ginseng root are trace-level, typically in the range of 0.001–0.05% dry weight, varying by species, plant age, and processing method. Bioavailability as an isolated compound is limited by poor aqueous solubility (logP estimated ~2.5–3.5), though its smaller sugar chain compared to major ginsenosides (e.g., Rg1) may confer relatively improved intestinal permeability. ADMET predictions suggest moderate oral absorption with potential for passive diffusion across cell membranes. No established dietary reference intake or recommended dose exists; research doses in in vitro studies typically range from 1–100 μM.

Preparation & Dosage

No clinically studied dosage ranges are available due to the absence of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Panax ginseng, Rhodiola rosea, Ashwagandha, Turmeric, Green tea extract

Safety & Interactions

Safety data for isolated ginsenoside F1 is limited due to its recent identification and study. As a ginseng-derived compound, it may share similar contraindications with ginseng, including potential interactions with anticoagulant medications and blood sugar-lowering drugs. Pregnant and nursing women should avoid supplementation due to insufficient safety data. Individuals with hormone-sensitive conditions should consult healthcare providers before use, as ginsenosides may have estrogenic activity.